Viking Therapeutics Is Great. Here’s Why You Shouldn’t Buy It.
Shares of the clinical-stage biotech have skyrocketed on recent good news.
Mindfully Curated
Shares of the clinical-stage biotech have skyrocketed on recent good news.
This exchange-traded fund is poised to be a big winner over the next few years.
One analyst thinks Meta Platforms has “too many advantages to count.”
There could be a light at the end of the tunnel for this beaten-down stock.
Ark Invest bought more shares of companies down heavily.
The Oracle of Omaha likely sent two brand-name companies to the chopping block in the first quarter. But at the same time, he’s been actively buying shares of two top-tier businesses.
Three highly successful billionaire money managers are paring down their respective stakes in artificial intelligence (AI) titan Nvidia and purchasing shares of six beaten-down value stocks.
Which e-commerce stock is better positioned to earn higher returns?
Here’s everything you need to know about the electric vehicle maker’s week.
Shopify and Uber are affordable stocks that could make patient shareholders richer over the next five years.